共 50 条
- [23] Are upgraded DCE-positive PI-RADS 3 lesions truly suspicious for clinically significant prostate cancer? European Radiology, 2023, 33 : 5825 - 5827
- [25] MRI Based Radiomics Compared With the PI-RADS V2.1 in the Prediction of Clinically Significant Prostate Cancer: Biparametric vs Multiparametric MRI FRONTIERS IN ONCOLOGY, 2022, 11
- [26] PI-RADS 3 score: A retrospective experience of clinically significant prostate cancer detection BJUI COMPASS, 2023, 4 (04): : 473 - 481
- [28] Nomograms for predicting clinically significant prostate cancer in men with PI-RADS-3 biparametric magnetic resonance imaging AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (01):
- [29] Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (04): : 1 - 13
- [30] CLINICALLY SIGNIFICANT PROSTATE CANCER DETECTION RATES IN PI-RADS 3 LESIONS ON MPMRI: RISK STRATIFIED BY PSA DENSITY JOURNAL OF UROLOGY, 2024, 211 (05): : E313 - E313